chr2-71600843-G-T
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_001130987.2(DYSF):c.3897+1G>T variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_001130987.2 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive limb-girdle muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- neuromuscular disease caused by qualitative or quantitative defects of dysferlinInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- autosomal recessive limb-girdle muscular dystrophy type 2BInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- distal myopathy with anterior tibial onsetInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- congenital myopathy, Paradas typeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Miyoshi myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DYSF | NM_001130987.2 | c.3897+1G>T | splice_donor_variant, intron_variant | Intron 34 of 55 | ENST00000410020.8 | NP_001124459.1 | ||
| DYSF | NM_003494.4 | c.3843+1G>T | splice_donor_variant, intron_variant | Intron 34 of 54 | ENST00000258104.8 | NP_003485.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DYSF | ENST00000410020.8 | c.3897+1G>T | splice_donor_variant, intron_variant | Intron 34 of 55 | 1 | NM_001130987.2 | ENSP00000386881.3 | |||
| DYSF | ENST00000258104.8 | c.3843+1G>T | splice_donor_variant, intron_variant | Intron 34 of 54 | 1 | NM_003494.4 | ENSP00000258104.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1457594Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 725238
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin Pathogenic:1
This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 34 of the DYSF gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). Disruption of this splice site has been observed in individual(s) with dysferlinopathy (PMID: 16010686, 18853459). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at